Search clinical trials for: TAVI (Medtronic CoreValve)

Total 969 results

University of Leipzig

Unknown

CLaret Embolic Protection ANd TAVI - Trial (CLEAN-TAVI)

Frequency of Cerebral Perfusion Defects After TAVI | Size of Cerebral Perfusion Defects After TAVI

Germany
Deutsches Herzzentrum Muenchen

Recruiting

PROTECT TAVI - Prospective Randomized Outcome Study in TAVI Patients Undergoing Periprocedural Embolic Cerebral Protection With the Sentinel™ Device (PROTECT)

Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves

Germany
Medtronic Cardiovascular

Completed

Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement

Severe Aortic Stenosis

United States
Medtronic Cardiovascular

Active, not recruiting

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). (SURTAVI)

Severe Aortic Stenosis

United States, Netherlands, Canada, Spain, Denmark, United Kingdom, Switzerland, Germany, Sweden
Medtronic Cardiovascular

Active, not recruiting

Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement

Severe Aortic Stenosis

United States
Ceric Sàrl
Symetis SA

Completed

Safety and Efficacy Comparison Of Two TAVI Systems in a Prospective Randomized Evaluation II (SCOPE II)

Aortic Valve Stenosis

Germany, France, Spain, United Kingdom, Denmark, Italy
Medtronic Bakken Research Center

Completed

Medtronic CoreValve REDO Study (REDO)

Aortic Valve Stenosis

Netherlands, Germany
Medtronic Bakken Research Center

Completed

Clinical Evaluation of Percutaneous Implantation of the Medtronic CoreValve Aortic Valve Prosthesis (18Fr-Study)

Aortic Valve Stenosis

Netherlands, Canada, United Kingdom, Germany
Medtronic Cardiovascular

Completed

Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement

Severe Aortic Stenosis

United States
Medtronic Bakken Research Center

Completed

CoreValve Advance International Post Market Study

Severe Aortic Stenosis

Italy, Israel, Germany, Netherlands, Greece, France, Switzerland, United Kingdom, Portugal, Denmark, Belgium, Colombia
Medtronic Cardiovascular

Completed

Clinical Evaluation of MDT-2111 in Subjects With Symptomatic Severe Aortic Stenosis

Aortic Valve Stenosis

Japan
Medtronic Cardiovascular
Medtronic Australasia

Completed

CoreValve® System Australia/New Zealand Clinical Study

Aortic Valve Stenosis

New Zealand, Australia
Boston Scientific Corporation

Recruiting

ACURATE IDE: Safety and Effectiveness Study of ACURATE Valve for Transcatheter Aortic Valve Replacement

Aortic Stenosis

United States, Canada
Medtronic Cardiovascular
Medtronic

Terminated

The Medtronic Transcatheter Aortic Valve Implant System (CoreValve System Family) Post Marketing Surveillance (PMS) (CoreValve India PMS) (CoreValveIndia)

Symptomatic Aortic Stenosis

India
LMU Klinikum

Completed

Everyday Practice With Transcatheter Aortic Valve Implantation (EVERY-TAVI)

Aortic Valve Stenosis

Germany
Medtronic Cardiovascular

Completed

CoreValve™ Evolut R™ FORWARD Study (FORWARD)

Aortic Valve Stenosis

Netherlands, Saudi Arabia, Italy, Germany, Sweden, Spain, Australia, France, United Kingdom, Belgium, Greece, Hungary, Israel, Canada, Colombia, South Africa, Czechia, Norway, Panama, Poland, Portugal
Medtronic Cardiovascular

Active, not recruiting

Evolut PRO China Clinical Study

Severe, Symptomatic Aortic Stenosis

China
Medtronic Cardiovascular

Completed

Medtronic CoreValve Evolut R U.S. Clinical Study

Aortic Stenosis

United States
Medtronic Cardiovascular

Completed

Medtronic CoreValve Evolut R U.S. Clinical Study (Evolut 34R Addendum)

Aortic Valve Stenosis

United States
Vascular Innovations Co. Ltd.
MedPass International

Active, not recruiting

A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve

Aortic Valve Stenosis

New Zealand, Hong Kong, Thailand, Greece, Lithuania, Poland
UMC Utrecht

Terminated

Edwards SAPIEN-3 Periprosthetic Leakage Evaluation Versus Medtronic CoreValve in Transfemoral Aortic Valve Implantation (ELECT)

Periprosthetic Aortic Valve Regurgitation After TAVI

Netherlands
National and Kapodistrian University of Athens
University General Hospital of Heraklion; Naval Hospital, Athens; Silesian Centre... and other collaborators

Completed

Impact of Predilatation Between Self-expanding Valves (DIRECTII)

Aortic Stenosis

Greece
Medtronic Cardiovascular

Completed

FORWARD PRO Study Interventional Post-market Study With the Evolut™ PRO System

Aortic Valve Stenosis

Netherlands, France, Italy, Germany, Spain, Denmark, Belgium, United Kingdom, Slovenia, Finland, Austria, Israel, Norway, Switzerland
Rabin Medical Center
Mayo Clinic; IRCCS San Raffaele; Medical University of Vienna; University of British... and other collaborators

Unknown

Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry (AMTRAC)

Aortic Stenosis | Mitral Regurgitation

Israel
Medtronic Cardiovascular

Active, not recruiting

Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

Bicuspid Aortic Valve

United States
Edwards Lifesciences

Completed

SOURCE 3: Observational Study to Evaluate Safety and Performance of SAPIEN 3 THV System in Real Life Practice (SOURCE 3)

Aortic Stenosis

United Kingdom, Denmark, Germany, Switzerland, France, Netherlands, Finland, Italy, Slovakia, Spain
Edwards Lifesciences
University of British Columbia; Medstar Health Research Institute; European Cardiovascular...

Completed

CENTERA-2: Safety and Performance Study of the Edwards CENTERA-EU Self-Expanding Transcatheter Heart Valve

Aortic Valve Disease

Australia, Denmark, Germany, Switzerland, France, New Zealand, Italy, United Kingdom, Netherlands
Edwards Lifesciences

Completed

Safety and Performance Study of the Edwards SAPIEN 3 Transcatheter Heart Valve/ The SAPIEN 3 Study (SAPIEN3)

Aortic Valve Disease

United Kingdom, France, Germany, Italy, Canada
University of Athens

Recruiting

TAVI in Intermediate Risk Septuagenarians With Risk Factors Not Captured by the Traditional Surgical Risk Scores

Transcatheter Aortic Valve Replacement

Greece
Edwards Lifesciences

Completed

PARTNER II Trial: S3iCAP (PII S3i CAP)

Aortic Stenosis

United States, Canada
Edwards Lifesciences
University of British Columbia; Medstar Health Research Institute; European Cardiovascular...

Completed

Safety and Performance Study of the Edwards CENTERA Self-Expanding Transcatheter Heart Valve (CENTERA-1)

Aortic Valve Disease

Switzerland, Germany
Medical University of Warsaw

Recruiting

Polish Registry of Common Carotid Artery Access for TAVI (POL-CAROTID)

Aortic Valve Stenosis | Ventricular Outflow Obstruction, Left

Poland
Segeberger Kliniken GmbH

Completed

A Comparison of Transcatheter Heart Valves in High Risk Patients With Severe Aortic Stenosis: The CHOICE Trial (CHOICE)

Aortic Stenosis

Germany
Medtronic Cardiovascular
Medtronic

Completed

The Medtronic CoreValve™ Evolut R™ CE Mark Clinical Study

Aortic Stenosis

New Zealand, United Kingdom, Australia
Medtronic Cardiovascular

Recruiting

Evolut™ EXPAND TAVR II Pivotal Trial

Moderate Aortic Valve Stenosis

United States, France, Netherlands, Canada, Spain, Israel, Australia, Denmark, Germany, Italy, Japan, Switzerland, Belgium, Sweden, Austria, United Kingdom, Ireland
Edwards Lifesciences

Completed

SOURCE XT REGISTRY

Severe Aortic Stenosis

Spain, Italy, Canada, Belgium, Greece, Germany, Austria, United Kingdom, Finland, Denmark, France, Switzerland, Israel, Poland, South Africa, Czechia, Netherlands, Norway
IRCCS Policlinico S. Donato

Recruiting

OUTcomes Evaluation of Current Therapeutic STrategies for Severe Aortic Valve steNosis anD the agING Population in ITALY (OUTSTANDING)

Aortic Valve Stenosis

Italy
Abbott Medical Devices

Completed

5 Year Observation of Patients With PORTICO Valves (PORTICO-1)

Aortic Valve Stenosis

United Kingdom, Netherlands, Spain, Germany, Belgium, Australia, Denmark, Canada, Italy, France, Israel, Lithuania, Switzerland
Medstar Health Research Institute

Not yet recruiting

Randomized Evaluation for Failed TAVR (REVIVE-TAVR)

Prosthesis Failure | Prosthetic Valve Malfunction | Symptomatic Patients Who Have Had Transcatheter Heart Valve (THV) Failure
Ole De Backer
Boston Scientific Corporation; Abbott; Edwards Lifesciences; Symetis SA

Active, not recruiting

Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis (NOTION-2)

Heart Diseases | Cardiovascular Diseases | Aortic Valve Stenosis | Heart Valve Diseases | Ventricular Outflow Obstruction

Finland, Norway, Sweden, Denmark, Iceland
Medtronic Bakken Research Center

Completed

ADVANCE Direct Aortic Study

Aortic Stenosis | Valvular Heart Disease

Netherlands, United Kingdom, Czechia, France, Germany, Italy
Medical University of Warsaw

Recruiting

Polish Transcatheter Aortic Valve-in-Valve Implantation (ViV-TAVI) Registry

Aortic Valve Stenosis | Aortic Valve Insufficiency | Ventricular Outflow Obstruction, Left

Poland
Centre de Recherche de l'Institut Universitaire...

Active, not recruiting

Transcatheter Aortic Valve Replacement Versu Surgical Aortix Valve Replacement for Treating Elderly Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Prospective Randomized Study The VIVA Trial

Aortic Stenosis | Aortic Regurgitation | Degenerative Aortic Valve Disease

Canada
University Hospital, Bonn

Completed

Transcatheter Aortic Valve Implantation Without Predilation (SIMPLIFy TAVI)

Aortic Stenosis | Left Ventricular Function Systolic Dysfunction | High-risk Patients | Transcatheter Aortic Valve Implantation

Germany
University of Zurich

Recruiting

Optimal Timing of Transcatheter Aortic Valve Implantation and Percutaneous Coronary Intervention - The TAVI PCI Trial (TAVI-PCI)

Coronary Artery Disease | Aortic Stenosis | PCI | TAVI

Switzerland
Opsens, Inc.

Completed

SAvvyWire™ EFficacy and SafEty in Transcatheter Aortic Valve Implantation Procedures (SAFE-TAVI) (SAFE-TAVI)

Severe Aortic Stenosis

Spain
Royal Sussex County Hospital
National Institute for Cardiovascular Outcomes Research

Unknown

Direct Aortic vs Subclavian Access for TAVI: a Review of the Outcomes in the UK

Aortic Stenosis
Institut für Pharmakologie und Präventive Medizin
Edwards Lifesciences

Recruiting

The ReTAVI Prospective Observational Registry

Aortic Valve Stenosis | Structural Valve Degeneration | Structural Valve Deterioration

Austria, Spain, Switzerland, France, Italy, Germany, Poland, Canada, Israel, Netherlands, Portugal, United Kingdom
Institut für Pharmakologie und Präventive Medizin
Edwards Lifesciences

Completed

Feasibility And Safety of Early Discharge After Transfemoral Transcatheter Aortic Valve Implantation (FAST-TAVI)

Aortic Stenosis

United Kingdom, Italy, Netherlands
University of Aarhus
London North West Healthcare NHS Trust

Completed

Improving the Efficacy of Sacral Nerve Stimulation for Fecal Incontinence by Alteration of Stimulation Parameters

Fecal Incontinence

Denmark, United Kingdom

Search clinical trials for: TAVI (Medtronic CoreValve)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Switzerland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations